RecruitingNCT04055571

Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases


Sponsor

Methodist Health System

Enrollment

500 participants

Start Date

Mar 5, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, Texas(TX). The investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either investigator's patients or through a national database. Data will be analyzed primarily by the study conductors.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • All patients diagnosed and treated for pancreatic diseases, benign or malignant from 2005 to present
  • Age ≥18 years

Exclusion Criteria2

  • Patients that are not diagnosed with or treated for pancreatic diseases
  • Age < 18 years

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Trinity Surgical Consultants, Methodist Richardson Medical Center

Richardson, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04055571